A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

August 5, 2009

Primary Completion Date

August 1, 2014

Study Completion Date

August 25, 2014

Conditions
Ovarian CancerSolid Tumors
Interventions
DRUG

OSI-906

Administered orally

DRUG

Paclitaxel

Administered intravenously

Trial Locations (46)

2145

WestMead Hospital, Westmead

3199

Frankston Hospital, Frankston

3690

Border Medical Oncology, Wodonga

4101

Mater Adult Hospital, South Brisbane

5000

Royal Adelaide Hospital, North Terrace

6008

St. John of Gog Hospital, Subiaco, Subiaco

6009

Sir Charles Gairdner Hospital, Perth

6230

St. John of God Hospital, Bunbury, Bunbury

7250

Launceston General Hospital, Launceston

20141

Instituto Europeo di Oncologia, Milan

27710

Duke University Medical Center, Durham

28204

Blumenthal Cancer Center - Main, Charlotte

40138

Universitaria di Bologna Policlinico, Bologna

47906

Horizon Oncology Center, Lafayette

50005

University Hospital Hradec Kralove, Kralove

67100

Oncology IDI- IRCSS, Roma

70121

Ochsner Clinic Foundation, New Orleans

70852

University Hospital Ostrava, Ostrava- Poruba

73104

University of Oklahoma Health Sciences Center, Oklahoma City

85259

Mayo Clinic, Scottsdale

91012

Ospedale di Carpi, AUSL di Modena, Carpi

92868

Department of Obstetrics and Gynecology, University of California, Irvine, Orange

129128

Central Clinical Hospital, Moscow

143423

Moscow City Oncology Hospital, Moscow

198255

Sity Clinical Oncology, Saint Petersburg

212000

General University Hospital, Department of Obstetrics and Gynecology, Prague

249036

State Institution Medical Radiology Scientific Center, Obninsk

400015

Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala, Cluj-Napoca

Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie, Cluj-Napoca

540072

Clinical Caunty Hospital Mures, Mures

700106

Oncology Medical Centre SCM, Iași

07960

Morristown Memorial Hospital, Morristown

L8V 5C2

Juravinski Cancer Center, Hamilton

M5G 2M9

Princess Margaret Hospital, Toronto

H3T 1E2

McGill University, Montreal

20-090

III Oddzial Onkologii Ginekologicznej, Lublin

61 866

Oddzial Radioterapii, Poznan

61-878

Klinika Onkologii AM w Poznaniu, Poznan

CH-6500

Ospedale San Giovanni, Bellinzona

SM2 5PT

Drug Development Unit Royal Mardsen NHS Foundation Trust, Sutton

SW3 6JJ

Royal Marsden Hospital, London

WC1E 6BT

University College Hospital, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

Christie NHS Foundation Trust, Withington

HA62RN

Mount Vernon Cancer Center, Northwood

OX37LI

Churchill Hospital, Oxford

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00889382 - A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) | Biotech Hunter | Biotech Hunter